These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16257524)

  • 41. Identifying drug active pathways from gene networks estimated by gene expression data.
    Tamada Y; Imoto S; Tashiro K; Kuhara S; Miyano S
    Genome Inform; 2005; 16(1):182-91. PubMed ID: 16362921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated pharmacokinetics and pharmacodynamics in drug development.
    Dingemanse J; Appel-Dingemanse S
    Clin Pharmacokinet; 2007; 46(9):713-37. PubMed ID: 17713971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite.
    Ahlborn GJ; Nelson GM; Ward WO; Knapp G; Allen JW; Ouyang M; Roop BC; Chen Y; O'Brien T; Kitchin KT; Delker DA
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):400-16. PubMed ID: 18191166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
    Davidson ME; Kerepesi LA; Soto A; Chan VT
    Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding systemic sclerosis through gene expression profiling.
    Pendergrass SA; Whitfield ML; Gardner H
    Curr Opin Rheumatol; 2007 Nov; 19(6):561-7. PubMed ID: 17917536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications.
    Plager DA; Leontovich AA; Henke SA; Davis MD; McEvoy MT; Sciallis GF; Pittelkow MR
    Exp Dermatol; 2007 Jan; 16(1):28-36. PubMed ID: 17181634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug load in clinical trials: a neglected factor.
    Deckers CL; Hekster YA; Keyser A; Meinardi H; Renier WO
    Clin Pharmacol Ther; 1997 Dec; 62(6):592-5. PubMed ID: 9433387
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmaceutical relevance of drug transporter malfunctions.
    Lancaster CS; Sparreboom A
    Clin Pharmacol Ther; 2011 Apr; 89(4):471-4. PubMed ID: 21423235
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development.
    Rolan P; Atkinson AJ; Lesko LJ; ;
    Clin Pharmacol Ther; 2003 Apr; 73(4):284-91. PubMed ID: 12709718
    [No Abstract]   [Full Text] [Related]  

  • 50. [Administration of drugs through the skin].
    Dahlerup J
    Sygeplejersken; 1985 Mar; 85(10):17. PubMed ID: 3849115
    [No Abstract]   [Full Text] [Related]  

  • 51. Sex dependent pharmacokinetics and bioequivalence--time for a change.
    Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(3):e358-61. PubMed ID: 24214491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical-pharmacological questions on drug metabolism from the viewpoint of a dermatologist].
    Ippen H
    Arzneimittelforschung; 1969 May; 19(5):814-5. PubMed ID: 5819798
    [No Abstract]   [Full Text] [Related]  

  • 53. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.
    Peck CC; Barr WH; Benet LZ; Collins J; Desjardins RE; Furst DE; Harter JG; Levy G; Ludden T; Rodman JH
    J Pharm Sci; 1992 Jun; 81(6):605-10. PubMed ID: 1355792
    [No Abstract]   [Full Text] [Related]  

  • 54. Premarketing observational studies of population pharmacokinetics of new drugs.
    Sheiner LB; Benet LZ
    Clin Pharmacol Ther; 1985 Nov; 38(5):481-7. PubMed ID: 3931953
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapeutic drug monitoring.
    Vozeh S
    Clin Pharmacol Ther; 1988 Dec; 44(6):713-4. PubMed ID: 3197369
    [No Abstract]   [Full Text] [Related]  

  • 56. Applications of photoacoustic spectroscopy to problems in dermatology research.
    Campbell SD; Yee SS; Afromowitz MA
    IEEE Trans Biomed Eng; 1979 Apr; 26(4):220-7. PubMed ID: 437803
    [No Abstract]   [Full Text] [Related]  

  • 57. Age-related changes in drug concentration in skin and lungs of mice.
    Ohkoshi M; Oka T
    J Dermatol; 1984 Oct; 11(5):438-42. PubMed ID: 6085086
    [No Abstract]   [Full Text] [Related]  

  • 58. Properties of suction de-epithelialized skin relative to drug delivery.
    Svedman P; Lundin S
    Acta Pharm Nord; 1992; 4(2):115-6. PubMed ID: 1388755
    [No Abstract]   [Full Text] [Related]  

  • 59. Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studies.
    Beger RD
    Expert Rev Mol Diagn; 2007 Mar; 7(2):113-5. PubMed ID: 17331060
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pharmacodynamics biomarkers: application and considerations in clinical development].
    Mito S; Sakai M; Suzuki M
    Nihon Yakurigaku Zasshi; 2016; 148(6):302-304. PubMed ID: 27904008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.